Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro

Published:2019-11-22 Issue:4 Volume:87 Page:669-676
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Pötschke Rebecca,Gielen Gerrit,Pietsch Torsten,Kramm Christof,Klusmann Jan-Henning,Hüttelmaier Stefan,Kühnöl Caspar D.

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://www.nature.com/articles/s41390-019-0628-9.pdf

Reference40 articles.

1. Johnson, D. R. & O’Neill, B. P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 107, 359–364 (2012).

2. Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492–507 (2008).

3. Wolff, J. E. et al. Measuring performance status in pediatric patients with brain tumors-experience of the HIT-GBM-C protocol. Pediatr. Blood Cancer 55, 520–524 (2010).

4. Cohen, K. J. et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol. 13, 317–323 (2011).

5. Das, K. K. et al. Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome. Childs Nerv. Syst. 28, 2055–2062 (2012).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA binding proteins in cancer chemotherapeutic drug resistance;Frontiers in Cell and Developmental Biology;2024-01-24

2. Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass;Frontiers in Bioscience-Landmark;2023-04-24

3. Targeting the epigenome of cancer stem cells in pediatric nervous system tumors;Molecular and Cellular Biochemistry;2023-01-13

4. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery;Pharmaceutics;2022-12-24

5. Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy;Seminars in Cancer Biology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3